Schulteis Gery, Morse Andrew C, Liu Jian
Department of Anesthesiology, UC San Diego School of Medicine and VA San Diego Healthcare System, 3350 La Jolla Village Drive, San Diego, CA 92161-5085, USA.
Psychopharmacology (Berl). 2004 Oct;175(4):463-72. doi: 10.1007/s00213-004-1843-5.
Single injections with morphine can induce a state of acute opioid dependence in humans and animals, typically measured as precipitated withdrawal when an antagonist such as naloxone is administered 4-24 h after morphine. Repeated treatment with morphine results in further increases in naloxone potency, and prior work has shown that this progressive shift in naloxone potency requires repeated naloxone experience under some but not all experimental conditions.
The current study sought to further characterize the experimental conditions that support naloxone experience-dependent and experience-independent potentiation of precipitated suppression of operant responding in morphine pretreated rats, and to assess more directly whether conditioning mechanisms may contribute to the former process.
Rats trained on an FR15 schedule for food received a total of five vehicle or morphine injections (5.6 mg/kg SC) at 4, 8, or 22 h prior to an operant session in which a cumulative dose-effect function for naloxone-induced suppression of responding was determined. Separate groups of animals at each interval between morphine and naloxone received cumulative naloxone dosing after all morphine pretreatments (NAL ALL DAYS) or after just the first and last morphine pretreatment (NAL FIRST/LAST). Additional groups of rats at the 4 h MOR-NAL interval received most of their naloxone cumulative dose-effect experience in either the home cage or in the operant context with levers retracted.
Vehicle-pretreated (Morphine-Naive) rats showed little change in the naloxone dose-effect function even after five cumulative dose-effect determinations. With a single morphine pretreatment, naloxone potency was increased at 4 or 8 h post-morphine, but not at 22 h. With repeated morphine treatment, all MOR-NAL intervals resulted in significant shifts in naloxone potency across treatment days even when naloxone was administered only after the first and last morphine pretreatment. However, much greater shifts in naloxone potency were observed at 4-h and 8-h intervals when naloxone was administered on all treatment days. At the 22 h MOR-NAL interval, there was no further potentiation in naloxone potency with additional naloxone experience provided on the intermediate days. Finally, when the repeated naloxone experience occurred in the home cage at the 4-h interval, naloxone potency was identical to that seen after limited naloxone experience (NAL FIRST/LAST), and significantly less than naloxone potency in groups receiving repeated naloxone experience in the operant context.
The results suggest that conditioned withdrawal mechanisms may play a significant role in the initial development of opioid dependence.
单次注射吗啡可在人类和动物中诱发急性阿片类药物依赖状态,通常通过在注射吗啡后4 - 24小时给予拮抗剂(如纳洛酮)来测量诱发的戒断反应。重复使用吗啡会导致纳洛酮效力进一步增加,先前的研究表明,在某些但并非所有实验条件下,纳洛酮效力的这种渐进性变化需要重复给予纳洛酮。
本研究旨在进一步明确支持纳洛酮依赖经验和非依赖经验增强吗啡预处理大鼠操作性反应的诱发抑制的实验条件,并更直接地评估条件作用机制是否可能促成前一过程。
在FR15食物强化程序上训练的大鼠,在操作性实验前4、8或22小时接受总共五次溶剂或吗啡注射(5.6毫克/千克,皮下注射),在该操作性实验中确定纳洛酮诱发反应抑制的累积剂量 - 效应函数。在吗啡和纳洛酮之间的每个间隔时间,单独的动物组在所有吗啡预处理后(纳洛酮全疗程)或仅在第一次和最后一次吗啡预处理后(纳洛酮首次/末次)接受累积纳洛酮给药。在4小时吗啡 - 纳洛酮间隔时间的另外几组大鼠,在其大部分纳洛酮累积剂量 - 效应实验中,分别是在饲养笼中或在杠杆收起的操作性环境中进行。
溶剂预处理(未用吗啡)的大鼠即使在五次累积剂量 - 效应测定后,纳洛酮剂量 - 效应函数也几乎没有变化。单次吗啡预处理后,吗啡注射后4或8小时纳洛酮效力增加,但22小时时未增加。重复吗啡治疗后,即使仅在第一次和最后一次吗啡预处理后给予纳洛酮,所有吗啡 - 纳洛酮间隔时间在各治疗日的纳洛酮效力均有显著变化。然而,当在所有治疗日给予纳洛酮时,在4小时和8小时间隔观察到纳洛酮效力有更大的变化。在22小时吗啡 - 纳洛酮间隔时间,中间几天额外给予纳洛酮经验后,纳洛酮效力没有进一步增强。最后,当在4小时间隔的饲养笼中发生重复纳洛酮经验时,纳洛酮效力与有限纳洛酮经验(纳洛酮首次/末次)后的效力相同,且显著低于在操作性环境中接受重复纳洛酮经验的组的纳洛酮效力。
结果表明,条件性戒断机制可能在阿片类药物依赖的初始发展中起重要作用。